193 related articles for article (PubMed ID: 15579058)
1. Hypertension in peripheral arterial disease.
Clement DL; De Buyzere ML; Duprez DA
Curr Pharm Des; 2004; 10(29):3615-20. PubMed ID: 15579058
[TBL] [Abstract][Full Text] [Related]
2. Treatment of hypertension in peripheral arterial disease.
Lane DA; Lip GY
Cochrane Database Syst Rev; 2013 Dec; (12):CD003075. PubMed ID: 24307487
[TBL] [Abstract][Full Text] [Related]
3. Peripheral vascular disease and hypertension: a forgotten association?
Makin A; Lip GY; Silverman S; Beevers DG
J Hum Hypertens; 2001 Jul; 15(7):447-54. PubMed ID: 11464253
[TBL] [Abstract][Full Text] [Related]
4. Treatment of hypertension in peripheral arterial disease.
Lane DA; Lip GY
Cochrane Database Syst Rev; 2009 Oct; (4):CD003075. PubMed ID: 19821300
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of symptomatic peripheral arterial disease, modifiable risk factors, and appropriate use of drugs in the treatment of peripheral arterial disease in older persons seen in a university general medicine clinic.
Ness J; Aronow WS; Newkirk E; McDanel D
J Gerontol A Biol Sci Med Sci; 2005 Feb; 60(2):255-7. PubMed ID: 15814871
[TBL] [Abstract][Full Text] [Related]
6. Treatment of hypertension in peripheral arterial disease.
Lip GY; Makin AJ
Cochrane Database Syst Rev; 2003; (4):CD003075. PubMed ID: 14583959
[TBL] [Abstract][Full Text] [Related]
7. Characteristics and treatments of patients with peripheral arterial disease referred to UK vascular clinics: results of a prospective registry.
Khan S; Flather M; Mister R; Delahunty N; Fowkes G; Bradbury A; Stansby G
Eur J Vasc Endovasc Surg; 2007 Apr; 33(4):442-50. PubMed ID: 17196851
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic therapy for peripheral arterial disease and claudication.
Hiatt WR
J Vasc Surg; 2002 Dec; 36(6):1283-91. PubMed ID: 12469066
[TBL] [Abstract][Full Text] [Related]
9. Management of hypertension in peripheral arterial disease: does the choice of drugs matter?
Singer DR; Kite A
Eur J Vasc Endovasc Surg; 2008 Jun; 35(6):701-8. PubMed ID: 18375152
[TBL] [Abstract][Full Text] [Related]
10. Drug treatment of peripheral arterial disease in the elderly.
Aronow WS
Drugs Aging; 2006; 23(1):1-12. PubMed ID: 16492065
[TBL] [Abstract][Full Text] [Related]
11. Management of peripheral arterial disease and intermittent claudication.
Schainfeld RM
J Am Board Fam Pract; 2001; 14(6):443-50. PubMed ID: 11757887
[TBL] [Abstract][Full Text] [Related]
12. A review of simple, non-invasive means of assessing peripheral arterial disease and implications for medical management.
Ferreira AC; Macedo FY
Ann Med; 2010 Mar; 42(2):139-50. PubMed ID: 20156042
[TBL] [Abstract][Full Text] [Related]
13. Treatment of hypertension in patients with peripheral arterial disease: an update.
Clement DL
Curr Hypertens Rep; 2009 Aug; 11(4):271-6. PubMed ID: 19602328
[TBL] [Abstract][Full Text] [Related]
14. Medical treatment of peripheral arterial disease.
Hankey GJ; Norman PE; Eikelboom JW
JAMA; 2006 Feb; 295(5):547-53. PubMed ID: 16449620
[TBL] [Abstract][Full Text] [Related]
15. Intermittent claudication: a plea for guidelines for medical management.
Powell JT
Eur J Vasc Endovasc Surg; 2007 Apr; 33(4):451-2. PubMed ID: 17196850
[No Abstract] [Full Text] [Related]
16. Pharmacological interventions for peripheral artery disease.
Duprez DA
Expert Opin Pharmacother; 2007 Jul; 8(10):1465-77. PubMed ID: 17661729
[TBL] [Abstract][Full Text] [Related]
17. Control of hypertension in patients with peripheral artery disease.
Clement DL
Blood Press; 2006; 15(4):251-2. PubMed ID: 17078187
[No Abstract] [Full Text] [Related]
18. Statins and peripheral arterial disease: effects on claudication, disease progression, and prevention of cardiovascular events.
Coppola G; Novo S
Arch Med Res; 2007 Jul; 38(5):479-88. PubMed ID: 17560452
[TBL] [Abstract][Full Text] [Related]
19. Optimal medical management of peripheral arterial disease.
Rice TW; Lumsden AB
Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
[TBL] [Abstract][Full Text] [Related]
20. Intensive blood pressure control reduces the risk of cardiovascular events in patients with peripheral arterial disease and type 2 diabetes.
Mehler PS; Coll JR; Estacio R; Esler A; Schrier RW; Hiatt WR
Circulation; 2003 Feb; 107(5):753-6. PubMed ID: 12578880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
